The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Efficacy and cost of peripheral blood stem cell (PBSC) mobilization with low-dose cyclophosphamide (LD-CY) compared with plerixafor (P) in multiple myeloma (MM) patients (pts) treated with novel induction therapies.
Lubna Chaudhary
No relevant relationships to disclose
Farrukh Tauseef Awan
No relevant relationships to disclose
Aaron Cumpston
No relevant relationships to disclose
William W. Tse
No relevant relationships to disclose
Michael Craig
No relevant relationships to disclose
Mehdi Hamadani
No relevant relationships to disclose